ClotProtect Therapeutics
PrivateLast Round
Seed
Feb 18, 2026
Total Funding Raised
$1.62M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ClotProtect Therapeutics operates in Healthcare & Life Sciences and is based in Leeds. Its latest recorded funding round was a Seed round in February 2026.
ClotProtect Therapeutics is a biotechnology company that develops small molecule anti-fibrinolytic agents for the treatment of acute hemorrhage and traumatic bleeding.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ClotProtect Therapeutics Comparables
Compare ClotProtect Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lunac Therapeutics | 88% | |
| Coagulant Therapeutics Corporation | 54% | |
| Cayuga Biotech | 53% |
For institutional investors. Book with your work email.
ClotProtect Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 18, 2026 | ||||
| Pre Seed | Apr 22, 2024 |
For institutional investors. Book with your work email.
ClotProtect Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| University of Leeds | Pre Seed |
| Lifted Ventures | Seed |
| o2h ventures | Pre Seed |
| Innovate UK | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 18, 2026
$1.6M round led by Lifted Ventures.
- Apr 22, 2024
Led by o2h ventures with participation from University of Leeds.
For institutional investors. Book with your work email.
ClotProtect Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ClotProtect Therapeutics's valuation, stock price, and market status.
Is ClotProtect Therapeutics a public or private company?
ClotProtect Therapeutics is a private company.
What is the current stock price of ClotProtect Therapeutics?
ClotProtect Therapeutics is a private company, so its shares have no public market price. Caplight tracks ClotProtect Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ClotProtect Therapeutics worth (valuation)?
Valuation information for ClotProtect Therapeutics is not publicly available.
Can I buy ClotProtect Therapeutics stock?
ClotProtect Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ClotProtect Therapeutics's last funding round?
ClotProtect Therapeutics's most recent funding round was Seed on February 18, 2026.
Who are the main investors in ClotProtect Therapeutics?
Key investors in ClotProtect Therapeutics include Lifted Ventures, o2h ventures.
Will ClotProtect Therapeutics IPO soon?
No public IPO plans have been announced for ClotProtect Therapeutics.
How can I track ClotProtect Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in ClotProtect Therapeutics's shares on secondary markets.